75
Participants
Start Date
June 26, 2007
Primary Completion Date
March 26, 2010
Study Completion Date
June 23, 2010
daptomycin
6 mg/kg
daptomycin
8 mg/kg
vancomycin
1 gram
teicoplanin
6 mg/kg; used only at UK sites
nafcillin
1-2 gram
oxacillin
1-2 gram
flucloxacillin
1-2 mg
Lehigh Valley Hospital Trauma and Critical Care Research, Allentown
Rothman Institute, Philadelphia
Kane and Davis Associates, Washington D.C.
Wake Forest University Health Sciences, Winston-Salem
Infectious Disease Association of Tampa Bay, Tampa
Cleveland Clinic, Cleveland
Summa Health Systems, Akron
Regional Infectious Diseases-Infusion Center, Lima
Gundersen Clinic, LTD, La Crosse
Mayo Clinic, Rochester
Rush St. Luke's Medical Center, Chicago
Southern Illinois University School of Medicine, Springfield
South Denver Infectious Disease Associates, PC, Englewood
Idaho Falls Infectious Diseases, PLLC, Idaho Falls
Sierra Infectious Disease, Reno
"National Healthcare Institution of Moscow City Clinical Hospital #64", Moscow
"National Educational Institution of Higher Professional Education Saint Petersburg State Medical Academy n.a. Mechnikov of Roszdrav", Saint Petersburg
Russian Research Institute of Traumatology and Orthopedy, Saint Petersburg
"National Healthcare Institution Samara Regional Clinical Hospital n.a. Kalinin", Samara
"Federal Healthcare Institute Novosibirsk Scientific Research Institute of Traumatology and Orthopedy Rosmeditechnology", Novosibirsk
"Federal National Institution of Science Russian Ilizarov Scientific Center Restorative Traumatology and Orthopedics of Rosmedtechnology", Kurgan
UAMS College of Medicine, Little Rock
Dartmouth-Hitchcock Medical center, Lebanon
Nuffield Orthopaedics Centre, Bone Infection Unit, Headington, Oxford
The Royal Infirmary of Edinburgh at Little France, Edinburgh
Brownlee Centre - Gartnavel General Hospital, Glasgow
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INDUSTRY